12


/ Press Releases
2019.01
TWi launches generic Labetalol HCL Tablet
2018.12
TWi's ANDA of Metoprolol Succinate ER Tablet has been approved by US FDA
2018.11
TWi's ANDA of Oxcarbazepine ER Tablet has been tentatively approved by US FDA
2018.10
TWi successfully launches generic Bupropion Hydrochloride ER Tablet in TWi label
2018.09
TWi's ANDA of Diltiazem HCL ER Capsule has been approved by US FDA